Tests a device-based gaze training for dizziness in multiple sclerosis
Compares daily and intermittent gaze stability training for dizziness in adults with multiple sclerosis.
Plain-language title generated from the registry record
Registry title: Incremental Vestibulo-ocular Reflex Adaptation as a Novel Treatment for Dizziness in People With Multiple Sclerosis
Key facts
- Where
- Atlanta, United StatesSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 89 years old?
Source: NCT06495138, who can take part
Where in United States
- Emory UniveristyAtlanta, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Emory University
- Trial code
- NCT06495138
- Record updated
- 23 October 2026
- Original description
The study aims to study the effects of a novel treatment for vestibular symptoms in people with multiple sclerosis. The main objective is to determine whether daily personalized gaze stabilization training is more beneficial than intermittent gaze stability training in people with multiple sclerosis.Read full original descriptionShow less
Daily Versus Intermittent Incremental Vestibulo-ocular Reflex Adaptation as a Novel Treatment for Dizziness in People With Multiple Sclerosis
The study aims to study the effects of a novel treatment for vestibular symptoms in people with multiple sclerosis. The main objective is to determine whether daily personalized gaze stabilization training is more beneficial than intermittent gaze stability training in people with multiple sclerosis.
Inclusion: Neurologist-confirmed diagnosis of primary progressive or relapsing and remitting MS per The 2017 Revision of the McDonald Criteria and the Magnetic Resonance Imaging in MS, or a healthy volunteer without a diagnosis of multiple sclerosis or any related neurological conditions; Fluent in speaking and understanding English; Subjects with multiple sclerosis have self-reported vestibular symptoms of dizziness, imbalance, and/or a history of at least two falls in the prior 12 months.
Exclusion: Worsening MS symptoms during the prior 60 days; Immunotherapy change in the prior 60 days; Clinically isolated syndrome or radiologically isolated syndrome; Self-reported cognitive impairment that limits independence with basic and instrumental activities of daily living; Convergence insufficiency; Major orthopedic conditions that limit cervical spine range of motion or that alter walking; Systolic blood pressure > 180 mmHg and/or diastolic blood pressure > 90 mmHg at rest; Static visual acuity with correction of worse than 1.0 logMAR; Manifest ocular misalignment ≥ 5 diopters (e.g., tropia, lazy eye, strabismus}; Intra-nuclear ophthalmoplegia; Vestibular Migraine; Self-reported current or potential for pregnancy during enrollment; Ongoing participation in vestibular rehabilitation for dizziness.